Gene: PAQR5
Official Full Name: progestin and adipoQ receptor family member 5provided by HGNC
Gene Summary: Predicted to enable signaling receptor activity. Predicted to be involved in oogenesis. Predicted to be located in plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO15366 | PAQR5 Knockout cell line (HeLa) | Human | PAQR5 | 1:3~1:6 | Negative | Online Inquiry |
KO15367 | PAQR5 Knockout cell line (HCT 116) | Human | PAQR5 | 1:2~1:4 | Negative | Online Inquiry |
KO15368 | PAQR5 Knockout cell line (HEK293) | Human | PAQR5 | 1:3~1:6 | Negative | Online Inquiry |
KO15369 | PAQR5 Knockout cell line (A549) | Human | PAQR5 | 1:3~1:4 | Negative | Online Inquiry |
PAQR5 Gene Knockout Cell Lines represent a cutting-edge biological tool developed for the study of the PAQR5 gene, which is involved in various physiological processes through its role in regulating membrane signaling pathways. These cell lines have been engineered using CRISPR-Cas9 technology to achieve precise knockout of the PAQR5 gene, enabling researchers to elucidate the gene's function and its implications in cellular mechanisms and disease processes.
The primary function of these knockout cell lines is to facilitate the investigation of PAQR5's role in cell signaling, metabolism, and other crucial biological functions. By providing a controlled environment where PAQR5 is absent, researchers can study how its loss affects cellular behavior, including proliferation, apoptosis, and response to pharmacological agents. This knowledge is paramount in advancing our understanding of various diseases, including cancer and metabolic disorders, where alterations in PAQR5 expression may be involved.
In research and clinical settings, PAQR5 Gene Knockout Cell Lines are invaluable for drug discovery, biomarker identification, and therapeutic intervention studies. They serve as robust models for screening potential therapeutic compounds that target cellular pathways influenced by PAQR5, offering insights that could lead to innovative treatment options.
What sets our PAQR5 Gene Knockout Cell Lines apart from alternatives is not only their genetic precision but also the comprehensive accompanying support and resources we provide. Each line is thoroughly characterized, ensuring consistent performance and reproducibility essential for robust experimental outcomes. Furthermore, our product is backed by a wealth of scientific expertise and a commitment to quality that helps researchers confidently explore new frontiers in the life sciences.
For scientists and clinicians alike, investing in PAQR5 Gene Knockout Cell Lines means adopting a valuable resource that enhances experimental precision and broadens the scope of molecular investigation. Our company prides itself on supplying high-quality biological products, underpinned by years of rigorous research and development, providing you with the tools necessary for groundbreaking discoveries in your work.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.